Issue 2/2009
Content (8 Articles)
The role of gemtuzumab ozogamicin in combination chemotherapy regimens for primary resistant or relapsed acute myeloid leukemia
Hien K. Duong, Matt Kalaycio
Predicting the response of CML patients to tyrosine kinase inhibitor therapy
Deborah L. White, Timothy P. Hughes
Clinical implications of c-Kit mutations in acute myelogenous leukemia
Muriel Malaise, Daniel Steinbach, Selim Corbacioglu
MicroRNA expression in acute myeloid leukemia
Guido Marcucci, Michael D. Radmacher, Krzysztof Mrózek, Clara D. Bloomfield